Status:
NOT_YET_RECRUITING
Evaluating an Audiology Text-Message Protocol to Support Hearing Aid Use in NHS Adult Audiology Patients
Lead Sponsor:
WSAUD A/S
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
University of Nottingham
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Over 18 million adults in the United Kingdom have significant hearing loss, linked to isolation, depression and comorbidities. Hearing aids are the main management option yet are frequently unused (\~...
Detailed Description
Over 18 million adults in the UK have significant hearing loss, with prevalence and severity increasing with age. Hearing loss is a leading global cause of disability, associated with social isolation...
Eligibility Criteria
Inclusion
- WP1: Pilot Feasibility Study (n=60, 30 per group intervention/control (treatment as usual)) Inclusion criteria
- Aged ≥18 years (no upper age limit)
- Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss
- Able and willing to provide informed consent
- Not currently participating in similar research
- Access to a mobile device (This is not required to be a smart phone device)
- Exclusion criteria
- Registered on a pre-existing Florence text-messaging protocol.
- Unable to read/understand English
- WP2: Nested Process Evaluation (minimum n=10 patients, n=2 clinicians) Inclusion criteria (patients)
- Aged ≥18 years (no upper age limit)
- Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss
- Able and willing to provide informed consent
- Exclusion criteria (patients)
- Registered on a pre-existing Florence text-messaging protocol.
- Unable to read/understand English
- Inclusion criteria (clinicians)
- Aged ≥18 years (no upper age limit)
- Able and willing to provide informed consent
- Exclusion criteria (clinicians)
- • Not meeting criteria for inclusion
Exclusion
Key Trial Info
Start Date :
September 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07146607
Start Date
September 30 2025
End Date
December 1 2026
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QMC Ropewalk House
Nottingham, Nottinghamshire, United Kingdom, NG1 5DU